FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2480177654> ?p ?o ?g. }

• W2480177654 abstract "Introduction: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) may prevent colon cancer, but can cause serious gastrointestinal (GI), cardiovascular (CV), and renal side effects. Naproxen has a relatively favorable CV profile, but is notorious for its GI toxicity. To improve its safety profile, we developed NOSH-naproxen, where we linked nitric oxide (NO) and hydrogen sulfide (H2S) releasing moieties to the native molecule, the rational being the observations that NO and H2S may modulate some components of the local mucosal defense systems which should lead to reduced GI toxicity. Indeed, we recently reported that NOSH-naproxen displayed enhanced GI safety, with potent anti-inflammatory, analgesic, anti-pyretic, and anti-platelet properties. Here we describe the effects of NOSH-naproxen on the growth properties of several human colon cancer cell lines, and on its molecular targets in a xenograft mouse model of colon cancer. Methods: NOSH-naproxen was synthesized by us with 1H-NMR verification. Colon cancer cell lines: HT-29, HCT 15, and SW480; Cell growth: MTT. Xenografts: Male athymic nude (NU/NU) mice (N = 15) were implanted s.c. in the right flank with SW480 cells, when the tumors reached an average sizes of ∼100 mm3, the mice were randomly divided into 3 groups and gavaged daily with either vehicle (0.5% CMC) or equimolar concentrations of NOSH-naproxen (100 mg/kg) or naproxen (45 mg/kg). Tumor volume was measured every three days; after 30 days the mice were sacrificed, tumors collected, weighed, photographed and stored in formalin for IHC studies. Results: NOSH-naproxen inhibited the growth of HT-29, HCT 15, and SW480 cells with IC50 values of 90 ± 10, 100 ± 8, and 98 ± 7 nM at 24 hr, respectively. The corresponding IC50s for naproxen were 2800 ± 165, 2950 ± 215, and 3110 ± 185 nM. This represents an enhanced potency of ∼30,000-fold in the 3 cell lines at 24 h. In xenografts, all the mice treated with naproxen died within 2 weeks from what appeared to be GI bleeding. However, the NOSH-naproxen treated mice did not show any overt signs of toxicity. At sacrifice, NOSH-naproxen-treated mice had a mean reduction in tumor volume of 82%, and a mean reduction in tumor mass of 55%. NOSH-naproxen inhibited growth of these cancer cell xenografts as a result of reduced proliferation (decreased PCNA expression), and induction of apoptosis (increased number of TUNEL positive cells). NF-eB, activated in untreated xenografts was significantly inhibited by NOSH-naproxen. Other molecular targets affected by NOSH-naproxen were: induction of iNOS, significant reduction in FoxM1, and increases in p53. Conclusions: NOSH-naproxen is more potent and efficacious than naproxen and appears to be significantly safer. It targets parameters important in determining cellular kinetics, inflammation, and signaling pathways important in the carcinogenic process. Citation Format: Pascale L. Duvalsaint, Mitali Chattopadhyay, Ravinder Kodela, Khosrow Kashfi. Molecular targets of NOSH-naproxen (AVT-219), a dual nitric oxide and hydrogen sulfide-releasing hybrid, in a xenograft mouse model of colon cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4841." @default.
• W2480177654 created "2016-08-23" @default.
• W2480177654 creator A5044785775 @default.
• W2480177654 creator A5048161268 @default.
• W2480177654 creator A5059669645 @default.
• W2480177654 creator A5082737345 @default.
• W2480177654 date "2016-07-15" @default.
• W2480177654 modified "2023-09-25" @default.
• W2480177654 title "Abstract 4841: Molecular targets of NOSH-naproxen (AVT-219), a dual nitric oxide and hydrogen sulfide-releasing hybrid, in a xenograft mouse model of colon cancer" @default.
• W2480177654 doi "https://doi.org/10.1158/1538-7445.am2016-4841" @default.
• W2480177654 hasPublicationYear "2016" @default.
• W2480177654 type Work @default.
• W2480177654 sameAs 2480177654 @default.
• W2480177654 citedByCount "0" @default.
• W2480177654 crossrefType "proceedings-article" @default.
• W2480177654 hasAuthorship W2480177654A5044785775 @default.
• W2480177654 hasAuthorship W2480177654A5048161268 @default.
• W2480177654 hasAuthorship W2480177654A5059669645 @default.
• W2480177654 hasAuthorship W2480177654A5082737345 @default.
• W2480177654 hasConcept C121608353 @default.
• W2480177654 hasConcept C126322002 @default.
• W2480177654 hasConcept C142724271 @default.
• W2480177654 hasConcept C178790620 @default.
• W2480177654 hasConcept C185592680 @default.
• W2480177654 hasConcept C204787440 @default.
• W2480177654 hasConcept C2778115740 @default.
• W2480177654 hasConcept C29730261 @default.
• W2480177654 hasConcept C502942594 @default.
• W2480177654 hasConcept C519581460 @default.
• W2480177654 hasConcept C526805850 @default.
• W2480177654 hasConcept C71924100 @default.
• W2480177654 hasConcept C98274493 @default.
• W2480177654 hasConceptScore W2480177654C121608353 @default.
• W2480177654 hasConceptScore W2480177654C126322002 @default.
• W2480177654 hasConceptScore W2480177654C142724271 @default.
• W2480177654 hasConceptScore W2480177654C178790620 @default.
• W2480177654 hasConceptScore W2480177654C185592680 @default.
• W2480177654 hasConceptScore W2480177654C204787440 @default.
• W2480177654 hasConceptScore W2480177654C2778115740 @default.
• W2480177654 hasConceptScore W2480177654C29730261 @default.
• W2480177654 hasConceptScore W2480177654C502942594 @default.
• W2480177654 hasConceptScore W2480177654C519581460 @default.
• W2480177654 hasConceptScore W2480177654C526805850 @default.
• W2480177654 hasConceptScore W2480177654C71924100 @default.
• W2480177654 hasConceptScore W2480177654C98274493 @default.
• W2480177654 hasLocation W24801776541 @default.
• W2480177654 hasOpenAccess W2480177654 @default.
• W2480177654 hasPrimaryLocation W24801776541 @default.
• W2480177654 hasRelatedWork W160922265 @default.
• W2480177654 hasRelatedWork W1968271399 @default.
• W2480177654 hasRelatedWork W2064250310 @default.
• W2480177654 hasRelatedWork W2259818095 @default.
• W2480177654 hasRelatedWork W2324594876 @default.
• W2480177654 hasRelatedWork W2333622912 @default.
• W2480177654 hasRelatedWork W2350608842 @default.
• W2480177654 hasRelatedWork W2353324923 @default.
• W2480177654 hasRelatedWork W2365250031 @default.
• W2480177654 hasRelatedWork W2373976089 @default.
• W2480177654 hasRelatedWork W2376695291 @default.
• W2480177654 hasRelatedWork W2385016874 @default.
• W2480177654 hasRelatedWork W2408991599 @default.
• W2480177654 hasRelatedWork W2418639739 @default.
• W2480177654 hasRelatedWork W2499658324 @default.
• W2480177654 hasRelatedWork W2559004056 @default.
• W2480177654 hasRelatedWork W2939059579 @default.
• W2480177654 hasRelatedWork W3017215849 @default.
• W2480177654 hasRelatedWork W3029798588 @default.
• W2480177654 hasRelatedWork W3030766920 @default.
• W2480177654 isParatext "false" @default.
• W2480177654 isRetracted "false" @default.
• W2480177654 magId "2480177654" @default.
• W2480177654 workType "article" @default.